2023-03-012024-02-292024-02-29false13944670A&O MEDICAL LTD2024-10-18iso4217:GBPxbrli:pure139446702023-03-01139446702024-02-29139446702023-03-012024-02-29139446702022-02-28139446702023-02-28139446702022-02-282023-02-2813944670bus:SmallEntities2023-03-012024-02-2913944670bus:AuditExempt-NoAccountantsReport2023-03-012024-02-2913944670bus:AbridgedAccounts2023-03-012024-02-2913944670bus:PrivateLimitedCompanyLtd2023-03-012024-02-2913944670core:WithinOneYear2024-02-2913944670core:AfterOneYear2024-02-2913944670core:WithinOneYear2023-02-2813944670core:AfterOneYear2023-02-2813944670core:ShareCapital2024-02-2913944670core:SharePremium2024-02-2913944670core:RevaluationReserve2024-02-2913944670core:OtherReservesSubtotal2024-02-2913944670core:RetainedEarningsAccumulatedLosses2024-02-2913944670core:ShareCapital2023-02-2813944670core:SharePremium2023-02-2813944670core:RevaluationReserve2023-02-2813944670core:OtherReservesSubtotal2023-02-2813944670core:RetainedEarningsAccumulatedLosses2023-02-2813944670core:LandBuildings2024-02-2913944670core:PlantMachinery2024-02-2913944670core:Vehicles2024-02-2913944670core:FurnitureFittings2024-02-2913944670core:OfficeEquipment2024-02-2913944670core:NetGoodwill2024-02-2913944670core:IntangibleAssetsOtherThanGoodwill2024-02-2913944670core:ListedExchangeTraded2024-02-2913944670core:UnlistedNon-exchangeTraded2024-02-2913944670core:LandBuildings2023-02-2813944670core:PlantMachinery2023-02-2813944670core:Vehicles2023-02-2813944670core:FurnitureFittings2023-02-2813944670core:OfficeEquipment2023-02-2813944670core:NetGoodwill2023-02-2813944670core:IntangibleAssetsOtherThanGoodwill2023-02-2813944670core:ListedExchangeTraded2023-02-2813944670core:UnlistedNon-exchangeTraded2023-02-2813944670core:LandBuildings2023-03-012024-02-2913944670core:PlantMachinery2023-03-012024-02-2913944670core:Vehicles2023-03-012024-02-2913944670core:FurnitureFittings2023-03-012024-02-2913944670core:OfficeEquipment2023-03-012024-02-2913944670core:NetGoodwill2023-03-012024-02-2913944670core:IntangibleAssetsOtherThanGoodwill2023-03-012024-02-2913944670core:ListedExchangeTraded2023-03-012024-02-2913944670core:UnlistedNon-exchangeTraded2023-03-012024-02-2913944670core:MoreThanFiveYears2023-03-012024-02-2913944670core:Non-currentFinancialInstruments2024-02-2913944670core:Non-currentFinancialInstruments2023-02-2813944670dpl:CostSales2023-03-012024-02-2913944670dpl:DistributionCosts2023-03-012024-02-2913944670core:LandBuildings2023-03-012024-02-2913944670core:PlantMachinery2023-03-012024-02-2913944670core:Vehicles2023-03-012024-02-2913944670core:FurnitureFittings2023-03-012024-02-2913944670core:OfficeEquipment2023-03-012024-02-2913944670dpl:AdministrativeExpenses2023-03-012024-02-2913944670core:NetGoodwill2023-03-012024-02-2913944670core:IntangibleAssetsOtherThanGoodwill2023-03-012024-02-2913944670dpl:GroupUndertakings2023-03-012024-02-2913944670dpl:ParticipatingInterests2023-03-012024-02-2913944670dpl:GroupUndertakingscore:ListedExchangeTraded2023-03-012024-02-2913944670core:ListedExchangeTraded2023-03-012024-02-2913944670dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-03-012024-02-2913944670core:UnlistedNon-exchangeTraded2023-03-012024-02-2913944670dpl:CostSales2022-02-282023-02-2813944670dpl:DistributionCosts2022-02-282023-02-2813944670core:LandBuildings2022-02-282023-02-2813944670core:PlantMachinery2022-02-282023-02-2813944670core:Vehicles2022-02-282023-02-2813944670core:FurnitureFittings2022-02-282023-02-2813944670core:OfficeEquipment2022-02-282023-02-2813944670dpl:AdministrativeExpenses2022-02-282023-02-2813944670core:NetGoodwill2022-02-282023-02-2813944670core:IntangibleAssetsOtherThanGoodwill2022-02-282023-02-2813944670dpl:GroupUndertakings2022-02-282023-02-2813944670dpl:ParticipatingInterests2022-02-282023-02-2813944670dpl:GroupUndertakingscore:ListedExchangeTraded2022-02-282023-02-2813944670core:ListedExchangeTraded2022-02-282023-02-2813944670dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-02-282023-02-2813944670core:UnlistedNon-exchangeTraded2022-02-282023-02-2813944670core:NetGoodwill2024-02-2913944670core:IntangibleAssetsOtherThanGoodwill2024-02-2913944670core:LandBuildings2024-02-2913944670core:PlantMachinery2024-02-2913944670core:Vehicles2024-02-2913944670core:FurnitureFittings2024-02-2913944670core:OfficeEquipment2024-02-2913944670core:AfterOneYear2024-02-2913944670core:WithinOneYear2024-02-2913944670core:ListedExchangeTraded2024-02-2913944670core:UnlistedNon-exchangeTraded2024-02-2913944670core:ShareCapital2024-02-2913944670core:SharePremium2024-02-2913944670core:RevaluationReserve2024-02-2913944670core:OtherReservesSubtotal2024-02-2913944670core:RetainedEarningsAccumulatedLosses2024-02-2913944670core:NetGoodwill2023-02-2813944670core:IntangibleAssetsOtherThanGoodwill2023-02-2813944670core:LandBuildings2023-02-2813944670core:PlantMachinery2023-02-2813944670core:Vehicles2023-02-2813944670core:FurnitureFittings2023-02-2813944670core:OfficeEquipment2023-02-2813944670core:AfterOneYear2023-02-2813944670core:WithinOneYear2023-02-2813944670core:ListedExchangeTraded2023-02-2813944670core:UnlistedNon-exchangeTraded2023-02-2813944670core:ShareCapital2023-02-2813944670core:SharePremium2023-02-2813944670core:RevaluationReserve2023-02-2813944670core:OtherReservesSubtotal2023-02-2813944670core:RetainedEarningsAccumulatedLosses2023-02-2813944670core:NetGoodwill2022-02-2813944670core:IntangibleAssetsOtherThanGoodwill2022-02-2813944670core:LandBuildings2022-02-2813944670core:PlantMachinery2022-02-2813944670core:Vehicles2022-02-2813944670core:FurnitureFittings2022-02-2813944670core:OfficeEquipment2022-02-2813944670core:AfterOneYear2022-02-2813944670core:WithinOneYear2022-02-2813944670core:ListedExchangeTraded2022-02-2813944670core:UnlistedNon-exchangeTraded2022-02-2813944670core:ShareCapital2022-02-2813944670core:SharePremium2022-02-2813944670core:RevaluationReserve2022-02-2813944670core:OtherReservesSubtotal2022-02-2813944670core:RetainedEarningsAccumulatedLosses2022-02-2813944670core:AfterOneYear2023-03-012024-02-2913944670core:WithinOneYear2023-03-012024-02-2913944670core:Non-currentFinancialInstrumentscore:CostValuation2023-03-012024-02-2913944670core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-03-012024-02-2913944670core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-03-012024-02-2913944670core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-03-012024-02-2913944670core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-03-012024-02-2913944670core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-03-012024-02-2913944670core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-03-012024-02-2913944670core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-03-012024-02-2913944670core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-03-012024-02-2913944670core:Non-currentFinancialInstrumentscore:CostValuation2024-02-2913944670core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-02-2913944670core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-02-2913944670core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-02-2913944670core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-02-2913944670core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-02-2913944670core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-02-2913944670core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-02-2913944670core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-02-2913944670core:Non-currentFinancialInstrumentscore:CostValuation2023-02-2813944670core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-02-2813944670core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-02-2813944670core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-02-2813944670core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-02-2813944670core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-02-2813944670core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-02-2813944670core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-02-2813944670core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-02-2813944670bus:Director12023-03-012024-02-29

A&O MEDICAL LTD

Registered Number
13944670
(England and Wales)

Unaudited Financial Statements for the Year ended
29 February 2024

A&O MEDICAL LTD
Company Information
for the year from 1 March 2023 to 29 February 2024

Director

OBAIDULLAH WAHEED

Company Secretary

RAJPUT, Asadullah Zia

Registered Address

Hamilton House
4a The Avenue
London
E4 9LD

Registered Number

13944670 (England and Wales)
A&O MEDICAL LTD
Balance Sheet as at
29 February 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Tangible assets31,6411,622
1,6411,622
Current assets
Stocks4175175
Debtors5-
Cash at bank and on hand3,0532,288
3,2332,463
Creditors amounts falling due within one year5(7,276)(4,755)
Net current assets (liabilities)(4,043)(2,292)
Total assets less current liabilities(2,402)(670)
Net assets(2,402)(670)
Capital and reserves
Called up share capital100100
Profit and loss account(2,502)(770)
Shareholders' funds(2,402)(670)
The financial statements were approved and authorised for issue by the Director on 18 October 2024, and are signed on its behalf by:
OBAIDULLAH WAHEED
Director
Registered Company No. 13944670
A&O MEDICAL LTD
Notes to the Financial Statements
for the year ended 29 February 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Revenue from sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Straight line (years)
Office Equipment4
Stocks and work in progress
Stocks are valued at the lower of cost and estimated selling price (less any associated costs to enable such sales to complete).
2.Average number of employees

20242023
Average number of employees during the year22
3.Tangible fixed assets

Total

£
Cost or valuation
At 01 March 232,163
Additions746
At 29 February 242,908
Depreciation and impairment
At 01 March 23541
Charge for year727
At 29 February 241,268
Net book value
At 29 February 241,641
At 28 February 231,622
4.Stocks
Stocks are valued at the lower of cost and estimated selling price (less any associated costs to enable such sales to complete).

2024

2023

££
Finished goods175175
Total175175
5.Creditors: amounts due within one year

2024

2023

££
Other creditors3,2762,755
Accrued liabilities and deferred income4,0002,000
Total7,2764,755
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.